Item Type | Name |
Concept
|
Sarcoma
|
Concept
|
Sarcoma, Alveolar Soft Part
|
Concept
|
Sarcoma, Synovial
|
Concept
|
Sarcoma, Ewing
|
Academic Article
|
Targeted therapies for sarcomas: new roles for the pathologist.
|
Academic Article
|
Universal marker and detection tool for human sarcoma circulating tumor cells.
|
Academic Article
|
New drugs and combinations for the treatment of soft-tissue sarcoma: a review.
|
Academic Article
|
NY-ESO-1 (CTAG1B) expression in mesenchymal tumors.
|
Academic Article
|
Potential for immunotherapy in soft tissue sarcoma.
|
Academic Article
|
Analysis of the intratumoral adaptive immune response in well differentiated and dedifferentiated retroperitoneal liposarcoma.
|
Academic Article
|
Analysis of the Intratumoral Adaptive Immune Response in Well Differentiated and Dedifferentiated Retroperitoneal Liposarcoma
|
Academic Article
|
Soft Tissue Sarcomas
|
Academic Article
|
CDK4/6 Inhibitors Sensitize Rb-positive Sarcoma Cells to Wee1 Kinase Inhibition through Reversible Cell-Cycle Arrest.
|
Academic Article
|
Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
|
Academic Article
|
Molecular profiling of sarcomas: new vistas for precision medicine.
|
Academic Article
|
Detection of circulating tumor cells from cryopreserved human sarcoma peripheral blood mononuclear cells.
|
Academic Article
|
Long-Term Survival According to Histology and Radiologic Response to Preoperative Chemotherapy in 126 Patients Undergoing Resection of Non-GIST Sarcoma Liver Metastases.
|
Academic Article
|
Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults.
|
Academic Article
|
Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors.
|
Academic Article
|
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma.
|
Academic Article
|
Progressive and Reversible Conduction Disease With Checkpoint Inhibitors.
|
Academic Article
|
First-in-Human Treatment With a Dendritic Cell-targeting Lentiviral Vector-expressing NY-ESO-1, LV305, Induces Deep, Durable Response in Refractory Metastatic Synovial Sarcoma Patient.
|
Academic Article
|
Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion.
|
Academic Article
|
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials.
|
Academic Article
|
Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy.
|
Academic Article
|
Concomitant organ resection does not improve outcomes in primary retroperitoneal well-differentiated liposarcoma: A retrospective cohort study at a major sarcoma center.
|
Academic Article
|
Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case Report.
|
Academic Article
|
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.
|
Academic Article
|
Olaratumab in the management of advanced soft tissue sarcoma.
|
Academic Article
|
MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma.
|
Academic Article
|
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1.
|
Academic Article
|
Genomics, Morphoproteomics, and Treatment Patterns of Patients with Alveolar Soft Part Sarcoma and Response to Multiple Experimental Therapies.
|
Academic Article
|
Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States.
|
Academic Article
|
PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma.
|
Academic Article
|
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma.
|
Academic Article
|
A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1.
|
Academic Article
|
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN).
|
Academic Article
|
Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center.
|
Academic Article
|
Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions.
|
Academic Article
|
New Drug Approvals for Sarcoma in the Last 5 Years.
|
Academic Article
|
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.
|
Academic Article
|
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102).
|
Academic Article
|
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial.
|
Academic Article
|
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial.
|
Academic Article
|
The immune landscape of undifferentiated pleomorphic sarcoma.
|
Academic Article
|
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time.
|
Academic Article
|
Case report: Responses to the combination of gemcitabine with sirolimus in two patients with TSC-mutated sarcomas.
|
Academic Article
|
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer.
|
Academic Article
|
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101).
|
Academic Article
|
SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection.
|
Academic Article
|
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma.
|